Cargando…

An Energy Metabolism Study on the Efficacy of Naoxintong Capsules against Myocardial Infarction in a Rat Model

BACKGROUND: In myocardial ischemia, optimizing the myocardial metabolic phenotype to improve cardiac function is critical. Naoxintong capsules (NXT) are widely prescribed in Chinese medicine for the treatment of cerebrovascular and cardiovascular diseases. METHODS: In this study, a rat model of myoc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Jie, Ouyang, Yi, Wang, Huanhuan, Lai, Huaqing, Hu, Shaowei, Tang, Liying, Yang, Hongjun, Wu, Hongwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9338863/ https://www.ncbi.nlm.nih.gov/pubmed/35915610 http://dx.doi.org/10.1155/2022/3712500

Ejemplares similares

Specific DNA identification of Pheretima in the Naoxintong capsule
por: Zhu, Xiaoxiao, et al.
Publicado: (2019)

Meta-Analysis of Naoxintong Capsule for Patients with Vascular Dementia
por: Li, Li, et al.
Publicado: (2022)

Effect of Naoxintong Capsules on the Activities of CYP450 and Metabolism of Metoprolol Tartrate in Rats Evaluated by Probe Cocktail and Pharmacokinetic Methods
por: Ouyang, Huizi, et al.
Publicado: (2019)

A Metabonomics Investigation into the Therapeutic Effects of BuChang NaoXinTong Capsules on Reversing the Amino Acid-Protein Interaction Network of Cerebral Ischemia
por: Xu, Jing, et al.
Publicado: (2019)

Integrated metabolomics and gut microbiome to the effects and mechanisms of naoxintong capsule on type 2 diabetes in rats
por: Yan, Zenghao, et al.
Publicado: (2020)

Naoxintong Capsule Alternates Gut Microbiota and Prevents Hyperlipidemia in High-Fat-Diet Fed Rats
por: Lu, Yihang, et al.
Publicado: (2022)

Efficacy and safety of Naoxintong capsule for acute ischemic stroke: A protocol for systematic review and meta-analysis
por: Li, Na, et al.
Publicado: (2021)

Systematical Identification of the Protective Effect of Danhong Injection and BuChang NaoXinTong Capsules on Transcription Factors in Cerebral Ischemia Mice Brain
por: Xu, Jing, et al.
Publicado: (2020)

Efficacy and safety of Naoxintong capsule for treating chronic stable angina: study protocol for a randomized controlled trial
por: Huanjia, Gao, et al.
Publicado: (2021)

Protective effects of Naoxintong capsule alone and in combination with ticagrelor and atorvastatin in rats with Qi deficiency and blood stasis syndrome
por: Zhang, Wei-jian, et al.
Publicado: (2020)

The Effect of Naoxintong Capsule in the Treatment of Patients with Cerebral Infarction and Carotid Atherosclerosis: A Systematic Review and Meta-Analysis of Randomized Trials
por: Liang, Qiuer, et al.
Publicado: (2018)

NaoXinTong Capsules inhibit the development of diabetic nephropathy in db/db mice
por: Yang, Shu, et al.
Publicado: (2018)

Myocardial protective effect and transcriptome profiling of Naoxintong on cardiomyopathy in zebrafish
por: Hu, Mengyan, et al.
Publicado: (2021)

Naoxintong capsule delay the progression of diabetic kidney disease: A real-world cohort study
por: Zhang, Yuqing, et al.
Publicado: (2022)

Naoxintong Capsule Inhibits the Development of Cardiovascular Pathological Changes in Bama Minipig Through Improving Gut Microbiota
por: Zhang, Wei-jian, et al.
Publicado: (2019)

The effectiveness and safety of Naoxintong capsules in the treatment of vascular dementia: A protocol for systematic review and meta-analysis
por: Li, Yan-Lin, et al.
Publicado: (2021)

Evaluation of the anti-inflammatory and antioxidant pharmcodynamic compoents of naoxintong capsules as a basis of broad spectrum effects
por: Lv, Bin, et al.
Publicado: (2021)

Integrated UPLC-Q/TOF-MS Technique and MALDI-MS to Study of the Efficacy of YiXinshu Capsules Against Heart Failure in a Rat Model
por: Xu, Jing, et al.
Publicado: (2019)

Pharmacokinetics of Caffeic Acid, Ferulic Acid, Formononetin, Cryptotanshinone, and Tanshinone IIA after Oral Administration of Naoxintong Capsule in Rat by HPLC-MS/MS
por: Li, Jin, et al.
Publicado: (2017)

Systems Pharmacology-Based Approach to Comparatively Study the Independent and Synergistic Mechanisms of Danhong Injection and Naoxintong Capsule in Ischemic Stroke Treatment
por: Zhu, Junfeng, et al.
Publicado: (2019)

Experimental Evidence of Buyang Huanwu Decoction and Related Modern Preparations (Naoxintong Capsule and Yangyin Tongnao Granule) in Treating Cerebral Ischemia: Intestinal Microorganisms and Transcriptomics in Rats
por: Yin, Junjun, et al.
Publicado: (2022)

Naoxintong accelerates diabetic wound healing by attenuating inflammatory response
por: Fang, Leyu, et al.
Publicado: (2021)

Comparison of Buyang Huanwu granules and Naoxintong capsules in the treatment of stable angina pectoris: rationale and design of a randomized, blinded, multicentre clinical trial
por: Wang, Yu, et al.
Publicado: (2022)

Qiliqiangxin Capsules Optimize Cardiac Metabolism Flexibility in Rats With Heart Failure After Myocardial Infarction
por: Cheng, Wenkun, et al.
Publicado: (2020)

Identification of “Multiple Components-Multiple Targets-Multiple Pathways” Associated with Naoxintong Capsule in the Treatment of Heart Diseases Using UPLC/Q-TOF-MS and Network Pharmacology
por: Ma, Xianghui, et al.
Publicado: (2016)

Treatment of Danhong Injection Combined with Naoxintong Capsule in Acute Coronary Syndrome Patients Undergoing PCI Operation: Study for a Randomized Controlled and Double-Blind Trial
por: Zhao, Shuai, et al.
Publicado: (2018)

In Vitro Assessment of Cytochrome P450 2C19 Potential of Naoxintong
por: Chen, Hui, et al.
Publicado: (2012)

NaoXinTong Inhibits the Development of Diabetic Retinopathy in db/db Mice
por: Liu, Mengyang, et al.
Publicado: (2015)

Naoxintong/PPARγ Signaling Inhibits Cardiac Hypertrophy via Activation of Autophagy
por: Yuan, Shuping, et al.
Publicado: (2017)

Protective Effect of Qiliqiangxin Capsule on Energy Metabolism and Myocardial Mitochondria in Pressure Overload Heart Failure Rats
por: Zhang, Junfang, et al.
Publicado: (2013)

Naoxintong attenuates Ischaemia/reperfusion Injury through inhibiting NLRP3 inflammasome activation
por: Wang, Yaqiong, et al.
Publicado: (2016)

Danqi soft capsule prevents infarct border zone remodelling and reduces susceptibility to ventricular arrhythmias in post‐myocardial infarction rats
por: Ma, Shiyu, et al.
Publicado: (2019)

Naoxintong Retards Atherosclerosis by Inhibiting Foam Cell Formation through Activating PPARα Pathway
por: Wang, Zeng, et al.
Publicado: (2018)

Energy Drinks and Myocardial Infarction
por: Wajih Ullah, Muhammad, et al.
Publicado: (2018)

Mechanisms Underlying the Cardioprotection of YangXinDingJi Capsule against Myocardial Ischemia in Rats
por: Liu, Miaomiao, et al.
Publicado: (2020)

Effect of Xuefu Zhuyu Capsule on Myocardial Infarction: Network Pharmacology and Experimental Verification
por: Duan, Jinlong, et al.
Publicado: (2023)

Shensong Yangxin capsule reduces atrial fibrillation susceptibility by inhibiting atrial fibrosis in rats with post-myocardial infarction heart failure
por: Ma, Jin, et al.
Publicado: (2018)

Qishen capsule safely boosts cardiac function and angiogenesis via the MEK/ERK pathway in a rat myocardial infarction model
por: Guo, Cai-Xia, et al.
Publicado: (2019)

Evaluation of cardiac function at different time points after myocardial infarction of rats
por: Hu, Huiyuan, et al.
Publicado: (2012)

Naoxintong/PPARα Signaling Inhibits H9c2 Cell Apoptosis and Autophagy in Response to Oxidative Stress
por: Xu, Huimin, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_hqv2hptvrtg6gakmt5ro7eo8bn